Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Hüttel

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Biotechnology Advances|February 11, 2019
Biological and chemical diversity go hand in hand: Basidiomycota as source of new pharmaceuticals and agrochemicalsBirthe Sandargo, Clara Chepkirui, Tian Cheng, et al.
ACS Chemical Biology|February 2, 2018
Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor DevelopmentAlexander von Tesmar, Michael Hoffmann, Antoine Abou Fayad, et al.
Organic Letters|May 24, 2012
Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter"Alberto Plaza, Ronald Garcia, Giuseppe Bifulco, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2014
Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activitySascha Baumann, Jennifer Herrmann, Ritesh Raju, et al.
Organic Letters|February 9, 2019
Cystobactamids 920-1 and 920-2: Assignment of the Constitution and Relative Configuration by Total SynthesisTherese Planke, María Moreno, Stephan Hüttel, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2017
Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram-Negative PathogensStephan Hüttel, Giambattista Testolin, Jennifer Herrmann, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2011
Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycinaTill F Schäberle, Waldemar Vollmer, Hans-Jörg Frasch, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug TransportersKatharina Rox, Annett Kühne, Jennifer Herrmann, et al.
Angewandte Chemie (International Ed. in English)|April 26, 2018
Biosynthesis and Heterologous Production of Vioprolides: Rational Biosynthetic Engineering and Unprecedented 4-Methylazetidinecarboxylic Acid FormationFu Yan, David Auerbach, Yi Chai, et al.
Frontiers in Bioengineering and Biotechnology|September 26, 2022
A novel tumor-targeting strain of <i>Xenorhabdus stockiae</i> exhibits potent biological activitiesChao Zhang, Hanna Chen, Stephan Hüttel, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biotechnology Advances|February 11, 2019
Biological and chemical diversity go hand in hand: Basidiomycota as source of new pharmaceuticals and agrochemicalsBirthe Sandargo, Clara Chepkirui, Tian Cheng, et al.
ACS Chemical Biology|February 2, 2018
Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor DevelopmentAlexander von Tesmar, Michael Hoffmann, Antoine Abou Fayad, et al.
Organic Letters|May 24, 2012
Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter"Alberto Plaza, Ronald Garcia, Giuseppe Bifulco, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2014
Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activitySascha Baumann, Jennifer Herrmann, Ritesh Raju, et al.
Organic Letters|February 9, 2019
Cystobactamids 920-1 and 920-2: Assignment of the Constitution and Relative Configuration by Total SynthesisTherese Planke, María Moreno, Stephan Hüttel, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2017
Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram-Negative PathogensStephan Hüttel, Giambattista Testolin, Jennifer Herrmann, et al.
Antimicrobial Agents and Chemotherapy|June 22, 2011
Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycinaTill F Schäberle, Waldemar Vollmer, Hans-Jörg Frasch, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug TransportersKatharina Rox, Annett Kühne, Jennifer Herrmann, et al.
Angewandte Chemie (International Ed. in English)|April 26, 2018
Biosynthesis and Heterologous Production of Vioprolides: Rational Biosynthetic Engineering and Unprecedented 4-Methylazetidinecarboxylic Acid FormationFu Yan, David Auerbach, Yi Chai, et al.
Frontiers in Bioengineering and Biotechnology|September 26, 2022
A novel tumor-targeting strain of <i>Xenorhabdus stockiae</i> exhibits potent biological activitiesChao Zhang, Hanna Chen, Stephan Hüttel, et al.
Pageof 4